Table 4.
Location, classification, histology, and staging of lung cancer after HTX.
| Parameter | Lung Cancer after HTX (n = 41) |
|---|---|
| Location of lung cancer | |
| Right upper lobe, n (%) | 11 (26.8%) |
| Right middle lobe, n (%) | 1 (2.4%) |
| Right lower lobe, n (%) | 9 (22.0%) |
| Left upper lobe, n (%) | 17 (41.5%) |
| Left lower lobe, n (%) | 3 (7.3%) |
| Classification of lung cancer | |
| Small-cell lung cancer, n (%) | 3 (7.3%) |
| Non-small-cell lung cancer, n (%) | 38 (92.7%) |
| Histology of lung cancer | |
| Neuroendocrine carcinoma, n (%) | 3 (7.3%) |
| Adenocarcinoma, n (%) | 16 (39.0%) |
| Squamous-cell carcinoma, n (%) | 20 (48.8%) |
| Large-cell carcinoma, n (%) | 2 (4.9%) |
| Tumor (T) Staging | |
| T1a, n (%) | 0 (0.0%) |
| T1b, n (%) | 0 (0.0%) |
| T1c, n (%) | 1 (2.4%) |
| T2a, n (%) | 9 (22.0%) |
| T2b, n (%) | 7 (17.1%) |
| T3, n (%) | 8 (19.5%) |
| T4, n (%) | 16 (39.0%) |
| Lymph Node (N) Staging | |
| N0, n (%) | 9 (22.0%) |
| N1, n (%) | 6 (14.6%) |
| N2, n (%) | 14 (34.1%) |
| N3, n (%) | 12 (29.3%) |
| Metastasis (M) Staging | |
| M0, n (%) | 22 (53.7%) |
| M1a, n (%) | 8 (19.5%) |
| M1b, n (%) | 1 (2.4%) |
| M1c, n (%) | 10 (24.4%) |
| Stage according to UICC 8 | |
| IA, n (%) | 1 (2.4%) |
| IB, n (%) | 7 (17.1%) |
| IIA, n (%) | 0 (0.0%) |
| IIB, n (%) | 5 (12.2%) |
| IIIA, n (%) | 3 (7.3%) |
| IIIB, n (%) | 3 (7.3%) |
| IIIC, n (%) | 3 (7.3%) |
| IVA, n (%) | 10 (24.4%) |
| IVB, n (%) | 9 (22.0%) |
Abbreviations: HTX = heart transplantation; M = metastasis; N = lymph node; n = number; T = tumor; UICC 8 = 8th edition of the Union for International Cancer Control.